Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
Q2 2026 vs. Q1 2026
How the institutions holding Aclarion, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 10 | 15 | +5 |
| Shares | 112.6K | 115.3K | +2.75K (+2.4%) |
| Value | $368.1K | $332.1K | −$36.0K (−9.8%) |
New holders (7)
Institutions that held Aclarion, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 19,480 | $56.1K | 0.00% |
| Vanguard Fiduciary Trust Co | 16,028 | $46.2K | 0.00% |
| Susquehanna International Group, LLP | 15,355 | $44.2K | 0.00% |
| XTX Topco Ltd | 11,038 | $31.8K | 0.00% |
| Barclays PLC | 283 | $815 | 0.00% |
| Wells Fargo & Company | 100 | $288 | 0.00% |
| Caitong International Asset Management Co., Ltd | 4 | $12 | 0.00% |
Sold out (2)
Institutions that held Aclarion, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Dauntless Investment Group, LLC | 5,422 | $17.7K |
| Citigroup Inc | 1 | $3 |